Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
46,238
+0.55%
|
$508,618
$11.5 P/Share
|
|
Jul 30
2021
|
Jules A. Maltz Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
83,503
-0.41%
|
-
|
|
Jul 30
2021
|
Jules A. Maltz Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
113,917
+0.55%
|
$1,253,087
$11.5 P/Share
|
|
Jul 30
2021
|
Kristen Green Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
39,934
-0.41%
|
-
|
|
Jul 30
2021
|
Kristen Green Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
54,478
+0.55%
|
$599,258
$11.5 P/Share
|
|
Jul 30
2021
|
Institutional Venture Management Xv, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
83,503
-0.41%
|
-
|
|
Jul 30
2021
|
Institutional Venture Management Xv, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
113,917
+0.55%
|
$1,253,087
$11.5 P/Share
|
|
Jul 29
2021
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
408
-0.18%
|
-
|
|
Jul 29
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
556
+0.24%
|
$6,116
$11.5 P/Share
|
|
Jul 28
2021
|
Lynne Chou O'Keefe Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
646
-0.41%
|
-
|
|
Jul 28
2021
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
881
+0.55%
|
$9,691
$11.5 P/Share
|
|
Jul 28
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
81,078
-0.62%
|
-
|
|
Jul 28
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
110,610
+0.84%
|
$1,216,710
$11.5 P/Share
|
|
Jul 28
2021
|
Alex Bard Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
42,549
-0.41%
|
-
|
|
Jul 28
2021
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
58,046
+0.55%
|
$638,506
$11.5 P/Share
|
|
Jul 22
2021
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,529
-0.4%
|
-
|
|
Jul 22
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,085
+0.54%
|
$22,935
$11.5 P/Share
|
|
Jun 18
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,142
-10.59%
|
$265,704
$12.07 P/Share
|
|
Jun 18
2021
|
Spencer Lee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,690
-21.53%
|
$164,280
$12.07 P/Share
|
|
Jun 18
2021
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,571
-4.03%
|
$114,852
$12.07 P/Share
|
|
Jun 18
2021
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,368
-10.01%
|
$16,416
$12.07 P/Share
|
|
Jun 18
2021
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,829
-1.0%
|
$45,948
$12.07 P/Share
|
|
Jun 16
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,209
+16.47%
|
-
|
|
Jun 16
2021
|
Spencer Lee Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,667
+28.76%
|
-
|
|
Jun 16
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,340
+9.29%
|
-
|
|
Jun 16
2021
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,645
+29.24%
|
-
|
|
Jun 16
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,086
+2.56%
|
-
|
|
Jun 16
2021
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
565
+14.29%
|
-
|
|
May 24
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
196,553
-53.95%
|
$1,965,530
$10.56 P/Share
|
|
May 24
2021
|
Spencer Lee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
44,062
-53.75%
|
$440,620
$10.56 P/Share
|
|
May 24
2021
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
31,505
-12.87%
|
$315,050
$10.56 P/Share
|
|
May 24
2021
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,570
-24.27%
|
$25,700
$10.56 P/Share
|
|
May 24
2021
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,928
-0.78%
|
$29,280
$10.56 P/Share
|
|
May 20
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
364,339
+50.0%
|
-
|
|
May 20
2021
|
Spencer Lee Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
81,978
+50.0%
|
-
|
|
May 20
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104,271
+29.88%
|
-
|
|
May 20
2021
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,589
+50.0%
|
-
|
|
May 20
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,473
+2.2%
|
-
|
|
May 20
2021
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,824
+50.0%
|
-
|
|
Apr 16
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,000
+22.59%
|
$0
$0.4 P/Share
|
|
Jan 20
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
19,341,946
+50.0%
|
-
|
|
Jan 20
2021
|
Lynne Chou O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Indirect |
157,639
+50.0%
|
-
|
|
Jan 20
2021
|
Kristen Green Director |
BUY
Grant, award, or other acquisition
|
Indirect |
9,742,349
+50.0%
|
-
|
|
Jan 20
2021
|
Jules A. Maltz Director |
BUY
Grant, award, or other acquisition
|
Indirect |
20,373,064
+50.0%
|
-
|
|
Jan 20
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
367,735
+50.0%
|
-
|
|
Jan 20
2021
|
Alex Bard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
10,380,627
+50.0%
|
-
|
|
Jan 20
2021
|
Melissa Baird Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,458
+50.0%
|
-
|
|
Jan 20
2021
|
Oaktree Acquisition Holdings, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
3,773,437
+50.0%
|
-
|